Vitiligo
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
395
|
249
|
0.100 |
None |
1.000 |
5 |
5
|
2010 |
2016 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2017 |
Tonometry
|
phenotype |
|
Diagnostic Procedure
|
206
|
573
|
0.100 |
None |
1.000 |
3 |
3
|
2017 |
2018 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Stage 0 Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Squamous cell carcinoma of the head and neck
|
disease |
Neoplasms
|
Neoplastic Process
|
1543
|
348
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Squamous cell carcinoma of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
458
|
92
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.110 |
None |
1.000 |
2 |
1
|
2009 |
2019 |
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Soft tissue chondroma
|
disease |
Neoplasms
|
Neoplastic Process
|
6
|
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2005 |
Small Lymphocytic Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
120
|
122
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2017 |
Sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1453
|
144
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Seasonal Affective Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
57
|
17
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
30
|
12
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Rumination Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
33
|
13
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Respiratory Tract Diseases
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
198
|
109
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Progression of prostate cancer
|
disease |
|
Neoplastic Process
|
398
|
7
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.020 |
None |
1.000 |
2 |
3
|
2016 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |